INFUSION PUMPS MARKET ANALYSIS
Global Infusion Pump Market: Key Developments
In February 2023, Mindray announced the launch of BeneFusion i Series and u Series infusion systems featuring high precision, adaptive customization, and simplicity for guaranteed levels of medication safety in a variety of clinical settings.
In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received the marketing approval from China’s National Medical Products Administration (NMPA) for its independently-developed new AutoEx Chemotherapy Infusion Pump (AutoEx).
In November 2020, Baxter received Health Canada marketing authorization for its new Novum IQ Infusion Platform. The marketing authorization in Canada includes Novum IQ large volume (LVP) and syringe infusion pumps, representing Baxter’s latest developments.
In June 2019, the U.S. Food and Drug Administration (FDA) issued 510(k) clearance for the Ivenix Infusion System, ushering in a new era of infusion systems designed to make infusions safer, while lowering the total cost of ownership. The Ivenix Infusion System meet the new FDA guidelines to address the recurring safety problems associated with infusion pumps.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :